Literature DB >> 1354197

[Elevated serum levels of ICAM-1 in Wegener's granulomatosis].

S Hauschild1, W H Schmitt, J Kekow, C Szymkowiak, W L Gross.   

Abstract

Circulating soluble ICAM-1 (sICAM-1) isoforms are known to be elevated in inflammatory and autoimmune disorders (SLE, RA). A correlation between levels of circulating sICAM-1 and disease activity was described (5). In sera from 31 patients suffering from histologically confirmed Wegener's granulomatosis (WG) elevated levels of ICAM-1 were now detected in this primary systemic vasculitis. In generalized active disease circulating ICAM-1 levels were significantly higher when compared to remission and healthy control individuals. Sera from WG patients collected during intercurrent infections while on immunosuppressive drugs showed no elevation of circulating ICAM-1.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1354197

Source DB:  PubMed          Journal:  Immun Infekt


  4 in total

1.  Immunological and clinical follow up of hepatitis C virus associated cryoglobulinaemic vasculitis.

Authors:  P Lamprecht; F Moosig; A Gause; K Herlyn; E Csernok; H Hansen; W L Gross
Journal:  Ann Rheum Dis       Date:  2001-04       Impact factor: 19.103

2.  Elevated levels of soluble intercellular adhesion molecule-1 correlate with disease activity in Behçet's disease.

Authors:  A O Aydintuğ; G Tokgöz; K Ozoran; N Düzgün; A Gürler; H Tutkak
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

Review 3.  ANCA and associated diseases: immunodiagnostic and pathogenetic aspects.

Authors:  W L Gross; W H Schmitt; E Csernok
Journal:  Clin Exp Immunol       Date:  1993-01       Impact factor: 4.330

4.  Intercellular adhesion molecule-1 (ICAM-1) expression and soluble ICAM-1 (sICAM-1) production by cytokine-activated human aortic endothelial cells: a possible role for ICAM-1 and sICAM-1 in atherosclerotic aortic aneurysms.

Authors:  Z Szekanecz; M R Shah; W H Pearce; A E Koch
Journal:  Clin Exp Immunol       Date:  1994-11       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.